Bladder Cancer - Neoadjuvant Therapy with Cisplatin and Gemcitabine

被引：0
|
作者：
Schmid, Sebastian C. [1 ]
Gschwend, Juergen E. [1 ]
Retz, Margitta [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Urol Klin & Poliklin, D-80290 Munich, Germany
来源：
AKTUELLE UROLOGIE | 2013年 / 44卷 / 05期
关键词：
CHEMOTHERAPY; CYSTECTOMY;
D O I：
10.1055/s-0033-1356861
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：340 / 342
页数：5
相关论文
共 50 条
  • [21] Retrospective analysis of the efficacy and safety of neoadjuvant gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meleis, Laura
    Moore, Russell
    Inman, Brant A.
    Harrison, Michael R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (02) : 330 - 337
  • [22] Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer.
    Lattanzi, Michael
    Solovyov, Alexander
    Lihm, Jayon
    Quinlan, Colleen
    Whiting, Karissa
    Li, Hao
    Al-Ahmadie, Hikmat A.
    Teo, Min Yuen
    Aggen, David Henry
    Ostrovnaya, Irina
    Regazzi, Ashley Marie
    Jihad, Marwah
    Bajorin, Dean F.
    Balar, Arjun Vasant
    Mortazavi, Amir
    Merghoub, Taha
    Iyer, Gopa
    Rosenberg, Jonathan E.
    Greenbaum, Benjamin
    Funt, Samuel Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study
    Lyu, Q.
    Yang, X.
    Cao, Q.
    Zhuang, J.
    EUROPEAN UROLOGY, 2024, 85 : S1957 - S1957
  • [24] Gemcitabine plus cisplatin therapy, a safety regimen in advanced bladder cancer.
    Song, J
    Chung, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 452S - 452S
  • [25] Oncological Outcomes of Neoadjuvant Gemcitabine plus Carboplatin versus Gemcitabine plus Cisplatin in Locally Advanced Bladder Cancer: A Retrospective Analysis
    Mofid, Bahram
    Razzaghdoust, Abolfazl
    Ghajari, Mahdi
    Basiri, Abbas
    Fattahi, Mohammad-Reza
    Houshyari, Mohammad
    Jafari, Anya
    Taghizadeh-Hesary, Farzad
    UROLOGY JOURNAL, 2022, 19 (05) : 371 - 378
  • [26] Biomarker Exploration for neoadjuvant chemotherapy with gemcitabine combined with cisplatin in muscle-invasive bladder cancer.
    Wang, Kun
    Chen, Xusheng
    Zhang, Zhenting
    Hu, Hailong
    Zhang, Aili
    Wang, Xin
    Chen, Lijun
    Liu, Zhizhong
    Yue, Changjiu
    Zhang, Xueying
    Zhang, Menghuan
    Yao, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16556 - E16556
  • [27] Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade
    Goel, Sunny
    Sinha, Rahul J.
    Bhaskar, Ved
    Aeron, Ruchir
    Sharma, Ashish
    Singh, Vishwajeet
    ASIAN JOURNAL OF UROLOGY, 2019, 6 (03) : 222 - 229
  • [28] Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
    Matsubara, Nobuaki
    Mukai, Hirofumi
    Naito, Yoichi
    Nezu, Masahiko
    Itoh, Kuniaki
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 (04) : 310 - 317
  • [29] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Tislelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for lymph node-positive bladder cancer: Results of a prospective study.
    Yang, Xiao
    Zhuang, Juntao
    Cao, Qiang
    Cai, Lingkai
    Wu, Qikai
    Lu, Qiang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 619 - 619
12345